Enhancement of Geldanamycin Production by pH Shock in Batch Culture of Streptomyces hygroscopicus subsp. duamyceticus

  • Song, Jae-Yang (Department of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology) ;
  • Kim, Yoon-Jung (Department of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology) ;
  • Hong, Young-Soo (Korea Research Institute of Bioscience and Biotechnology) ;
  • Chang, Yong-Keun (Department of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology)
  • Published : 2008.05.31


Various sequences of pH change were applied in a batch bioreactor to investigate pH shock effects on geldanamycin production by Streptomyces hygroscopicus subsp. duamyceticus JCM4427. In the control culture where the pH was not controlled, the maximum geldanamycin concentration was 414 mg/l. With the pHS1 mode of pH shock, that is, an abrupt pH change from pH 6.5 to pH 5.0 and then being maintained at around pH 5.0 afterward, 768 mg/l of geldanamycin was produced. With pHS2, in which the pH was changed sequentially from pH 6.7 to pH 5.0 and then back to pH 6.0, 429 mg/l of geldanamycin was produced. With pHS3 having a sequential pH change from pH 6.0 to pH 4.0 and then back to pH 6.5 followed by the third pH shock to pH 5.5, no geldanamycin production was observed. Considering that the productivity with pHS1 was about two-fold of that of the control culture with no pH control, we concluded that a more sophisticated manipulation of pH would further promote geldanamycin production.


  1. Bibb, M. J. 1996 The regulation of antibiotic production in Streptomyces coelicolor A3(2). Microbiology 142: 1335-1344 https://doi.org/10.1099/13500872-142-6-1335
  2. Brunton, V. G., G. Steele, A. G. Lewis, and P. Workman. 1998. Geldanamycin induced cytotoxity in human colon-cancer cell lines: Evidence against the involvement of c-Src or DTdiaphorase. Cancer Chemother. Pharmacol. 41: 417-422 https://doi.org/10.1007/s002800050760
  3. Byrne, K. M., A. Shafiee, J. B. Nielsen, B. H. Arison, R. L. Monaghan, and L. Kaplan. 1993. The biosynthesis and enzymology of an immunosuppressant, immunomycin, produced by Streptomyces hygroscopicus var. ascomyciticus, pp. 29-45. In R. Hamill (ed.), Developments in Industrial Microbiology Series, Vol. 32. Wm. C. Brown Publisher, Dubuque, Iowa
  4. Chiosis, G., H. Huezo, N. Rosen, E. Mimnaugh, L. Whitesell, and L. Neckers. 2003. 17AAG: Low target binding affinity and potent cell activity - finding an explanation. Mol. Cancer Therap. 2: 123-129
  5. DeBoer, C. and A. Dietz. 1976. The description and antibiotic production of Streptomyces hygroscopicus var. geldanus. J. Antibiot. (Tokyo) 29: 1182-1188 https://doi.org/10.7164/antibiotics.29.1182
  6. DeBoer, C., P. A. Meulman, R. J. Wnuk, and D. H. Peterson. 1970. Geldanamycin, a new antibiotic. J. Antibiot. (Tokyo) 23: 442-447 https://doi.org/10.7164/antibiotics.23.442
  7. Doull, J. C., S. Y. Ayer, A. K. Singh, and P. Thibault. 1993. Production of a novel polyketide antibiotic, jadomycin B, by Streptomyces venezuelae following heat shock. J. Antibiot. 44: 869-871
  8. Harber, A., R. D. Johnson, and K. L. Jr. Rinehart. 1977. Biosynthetic origin of the $C_2$ units of geldanamycin and distribution of labeled form D-[6-$^{13}C$]glucose. J. Am. Chem. Soc. 99: 3541-3544 https://doi.org/10.1021/ja00452a079
  9. Hayes, A., G. Hobbs, C. P. Smith, S. G. Oliver, and P. R. Butler. 1997. Environmental signals triggering methylenomycin production by Streptomyces coelicolor A(3)2. J. Bacteriol. 179: 5511-5515 https://doi.org/10.1128/jb.179.17.5511-5515.1997
  10. Kieser, T., M. J. Bibb, M. J. Buttner, K. F. Chater, and D. A. Hopwood. 2000. Practical Streptomyces Genetics. John Innes Foundation, Norwich
  11. Kim, C. J., Y. K. Chang, and G.-T. Chun. 2000. Enhancement of kasugamycin production by pH shock in batch cultures of Streptomyces kasugaensis. Biotech. Prog. 16: 548-552 https://doi.org/10.1021/bp000038f
  12. Kim, Y. J., J. Y. Song, M. H. Moon, C. P. Smith, S.-K. Hong. and Y. K. Chang. 2007. pH shock induces overexpression of regulatory and biosynthetic genes for actinorhodin production in Streptomyces coelicolor A3(2). Appl. Microbiol. Biotechnol. 76: 1119-1130 https://doi.org/10.1007/s00253-007-1083-9
  13. Sausville, E. A., J. E. Tomaszewski, and P. Ivy. 2003. Clinical development of 17-allyamino, 17-demethoxygeldanamycin. Curr. Cancer Drug Targets 3: 377-383 https://doi.org/10.2174/1568009033481831
  14. Sevcikova, B. and J. Kormanec. 2004. Differential production of two antibiotics of Streptomyces coelicolor A3(2), actinorhodin and undecylprodigiosin, upon salt stress conditions. Arch. Microbiol. 181: 384-389 https://doi.org/10.1007/s00203-004-0669-1
  15. Supko, J. G., R. L. Hickman, M. R. Grever, and L. Malspeis. 1995. Preclinical phamacologenic evaluation of geldanamycin as an antitumor agent. Cancer Chemother. Pharmacol. 36: 305-315 https://doi.org/10.1007/BF00689048
  16. Workman, P. 2003. Auditing the pharmacological account for Hsp90 molecular chaperone inhibitor: Unfolding the relationship between pharmacokinetics and pharmacodynamics. Mol. Cancer Therap. 2: 131-138